Table 1.
Characteristics of the study group (n = 29).
| Parameter | n (%) |
|---|---|
| Age | |
| <60 | 5 (17.2%) |
| >60 | 24 (82.8%) |
| Gender | |
| male | 16 (55.2%) |
| female | 13 (44.8%) |
| Location | |
| sigmoid colon | 7 (24.2%) |
| rectum | 8 (27.6%) |
| cecum | 4 (13.8%) |
| ascending colon | 3 (10.3%) |
| hepatic fold | 4 (13.8%) |
| colon | 3 (10.3%) |
| Tumour size | |
| <3 cm | 5 (17.2%) |
| >3 cm | 24 (82.8%) |
| Histological type | |
| adenocarcinoma | 25 (86.2%) |
| mucinous adenocarcinoma | 4 (13.8%) |
| Depth of tumour invasion (pT) | |
| T1 | 0 (0.0%) |
| T2 | 10 (34.5%) |
| T3 | 19 (65.5%) |
| T4 | 0 (0.0%) |
| Lymph node metastasis (pN) | |
| N0 | 18 (62.1%) |
| N1+N2 | 11 (37.9%) |
| Distant metastasis (pM) | |
| M0 | 26 (89.7%) |
| M1 | 3 (10.3%) |
| Stage at diagnosis | |
| I | 8 (27.6%) |
| II | 7 (24.1%) |
| III | 10 (34.5%) |
| IV | 4 (13.8%) |
| Vascular invasion | |
| absent | 12 (41.4%) |
| present | 17 (58.6%) |
| Neural invasion | |
| absent | 21 (72.4%) |
| present | 8 (27.6%) |
| Inflammatory infiltration in the invasive front | |
| absent | 0 (0.0%) |
| weak | 14 (48.3%) |
| moderate | 11 (37.9%) |
| strong | 4 (13.8%) |
| Inflammatory infiltration in the tumour centre | |
| absent | 1 (34.5%) |
| weak | 15 (51.7%) |
| moderate | 11 (37.9%) |
| strong | 2 (6.9%) |
| Tumour budding (TB) | |
| 1 – <5 | 2 (6.9%) |
| 2 – 5–9 | 10 (34.5%) |
| 3 – >10 | 8 (27.6%) |
| 9 (31.0%) | |
| Poorly differentiated clusters (PDC) | |
| 1 – <5 | 0 (0.0%) |
| 2 – 5–9 | 29 (100.0%) |
| 3 – >10 | 0 (0.0%) |
| 0 (0.0%) | |
| Areas of poorly differentiated components (APDC) | |
| 0 | 0 (0.0%) |
| 1 – <10 | 29 (100.0%) |
| 2 – >10 | 0 (0.0%) |